Market Herald logo

Find out more about this capital raise

Be the first with the news that moves the market
  • Protean Energy (POW) has entered the week in a trading halt ahead of a capital raise
  • At this point in time, it is unclear how much the company is aiming to raise and what the cash injection will be put towards
  • Company shares will be paused until Wednesday, October 28, or when more details about the capital raise are released to the market
  • Last week, Protean announced GeoGeny Consultants Group will commence a four-phase exploration program at its Gwesan Vanadium Project in South Korea
  • Protean shares last traded for 1 cent on October 23

Protean Energy (POW) has entered the week in a trading halt ahead of a capital raise.

At this point in time, it is unclear how much the company is aiming to raise and what the cash injection will be put towards.

Protean’s shares will remain in a halt until Wednesday, October 28, or when more details about the capital raise are released to the market.

Last week, Protean gave GeoGeny Consultants the green light to commence a four-phase exploration program at its Gwesan Vanadium Project in South Korea.

The initial phase of the program is aiming to identify vanadium prospectivity at Gwesan. The company plans to undertake a field reconnaissance program — which includes multi-commodity soil and trench sampling campaigns, approvals and permits — in the first quarter of 2021.

Meanwhile, the second stage of the program will look to define anomalous zones of vanadium mineralisation, which will be followed by auger drilling and aeromagnetic surveying.

Based on these results, the company will then propose a diamond drill program to test vanadium targets.

Protean shares last traded for 1 cent on October 23.

POW by the numbers
More From The Market Herald

" Carnaby Resources (ASX:CNB) ends week in a trading halt

Carnaby Resources (ASX:CNB) enters a trading halt as it plans an upcoming capital raise.

" Askari Metals (ASX:AS2) plans to raise capital for lithium purchase

Askari Metals (AS2) has entered a trading halt as it plans an upcoming capital raise.
Telix Pharmaceuticals (ASX:TLX) - CEO, Christian Behrenbruch

" Telix Pharmaceuticals (ASX:TLX) planning capital raise

Telix Pharmaceuticals (ASX:TLX) enters a trading halt while it plans an upcoming capital raise.
Alice Queen (ASX:AQX) - Managing Director, Andrew Buxton

" Alice Queen (ASX:AQX) halts trade ahead of fresh capital

Mineral exploration company Alice Queen (ASX:AQX) has entered a trading halt ahead of a proposed capital…